NeuMoDx introduces high-vol nucleic acid extraction capability

Create PDF

“With the NeuMoDx Molecular solutions, our customers have had access to sophisticated, seamless workflows enabling continuous loading, true random access, and rapid turnaround times for sample-to-result IVD/LDT implementations,” Sundu Brahmasandra, NeuMoDx president and COO, said in a press release. “By extending these capabilities to include extraction only operation, our users can now harness the benefit of a high-throughput and universal nucleic acid extraction system that is able to simultaneously process a wide variety of clinical specimen matrices for high-quality DNA/RNA extractions.”